GlassScriptPhysician profile
Metul Shah
NPI 1659801231
$11,300.60
in general payments reported to CMS, 2019-2025
15 companies · $1,789 in 2025
The $1,789 reported for 2025 was more than what 96% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $466 · 2022: $2,791 · 2023: $4,704 · 2024: $1,550 · 2025: $1,789.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,489 · Grant: $1,875 · Travel and Lodging: $680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,488.55 |
| Grant | $1,875.00 |
| Travel and Lodging | $679.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,152.95 | 2021-2025 | Vercise, Wavewriter Alpha Prime 16, General - Pain Management |
| Medtronic, INC. | $1,204.11 | 2021-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Inceptiv |
| Spinal Simplicity, LLC | $1,033.80 | 2022 | |
| Spinefrontier, INC. | $686.77 | 2025 | Facetfuse, Inspan, Nanofuse |
| Vertos Medical, INC. | $461.98 | 2021-2023 | Mild Device Kit |
| Abbott Laboratories | $415.01 | 2021-2024 | Proclaim |
| Mml US, INC. | $401.88 | 2022-2023 | Reactiv8 |
| Saluda Medical Americas, INC. | $313.36 | 2023-2024 | Evoke Scs, Evoke |
| Painteq LLC | $212.13 | 2023 | Painteq |
| Relievant Medsystems, INC. | $153.95 | 2023 | Intracept |
| Bioventus LLC | $146.99 | 2023 | Stimrouter Implantable Kit |
| Depuy Synthes Sales INC. | $37.76 | 2022-2024 | Orthovisc, Monovisc |
| Forte Bio-Pharma LLC | $31.77 | 2023 | Prolate, Nalocet |
| Nevro Corp. | $28.38 | 2024 | Senza |
| Collegium Pharmaceutical, INC. | $19.76 | 2023 | Xtampza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Metul Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.